Patents by Inventor Xiangdong Wang

Xiangdong Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hepatitis C Virus Inhibitors
    Publication number: 20100150866
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: December 10, 2009
    Publication date: June 17, 2010
    Inventors: Alan Xiangdong Wang, Paul Michael Scola
  • Hepatitis C Virus Inhibitors
    Publication number: 20100081700
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: September 24, 2009
    Publication date: April 1, 2010
    Inventors: Alan Xiangdong Wang, Ramkumar Rajamani, Paul Michael Scola
  • Hepatitis C Virus Inhibitors
    Publication number: 20090304626
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: May 27, 2009
    Publication date: December 10, 2009
    Inventors: Alan Xiangdong Wang, Paul Michael Scola
  • Hepatitis C Virus Inhibitors
    Publication number: 20090297472
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: May 28, 2009
    Publication date: December 3, 2009
    Inventors: Alan Xiangdong Wang, Paul Michael Scola
  • Hepatitis C Virus Inhibitors
    Publication number: 20090274652
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: April 6, 2009
    Publication date: November 5, 2009
    Inventors: Ny Sin, Brian Lee Venables, Paul Michael Scola, Alan Xiangdong Wang
  • HEPATITIS C VIRUS INHIBITORS
    Publication number: 20090274648
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: November 14, 2007
    Publication date: November 5, 2009
    Inventors: Alan Xiangdong Wang, Barbara Zhizhen Zheng, Stanley D'Andrea, Qian Zhao, Paul Michael Scola
  • HEPATITIS C VIRUS INHIBITORS
    Publication number: 20090274656
    Abstract: Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R?, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: September 2, 2008
    Publication date: November 5, 2009
    Inventors: Alan Xiangdong Wang, Li-Qiang Sun, Sing-Yuen Sit, Ny Sin, Paul Michael Scola, Yan Chen
  • Advertisement Platform, System for Playing Advertisement and Method Thereof
    Publication number: 20080300969
    Abstract: The present invention discloses an Advertisement Platform (ADP), including an ADP Switch Point (ADP-SP), a voice playing unit and a service logic supporting unit; wherein the ADP-SP connects a call from a calling LS or an MS and initiates an advertisement service call to the service logic supporting unit; upon receiving the advertisement service call from the ADP-SP, the service logic supporting unit returns advertisement service instruction to the ADP-SP after parsing the advertisement service call; upon receiving the advertisement service instruction returned by the service logic supporting unit, the ADP-SP instructs the voice playing unit to play a ring back tone which includes advertisement according to the advertisement service instruction and connects a voice channel used for the voice playing unit playing advertisement with the calling voice channel or the MS voice channel. The present invention also discloses a system and method for playing advertisement.
    Type: Application
    Filed: May 15, 2006
    Publication date: December 4, 2008
    Applicant: Huawei Technologies Co., Ltd.
    Inventors: Deqiang Zhang, Xiangdong Wang, Haifeng Cui, Zhengjun Zhang, Chonghui Uang, Xiaoyi Dong
  • HEPATITIS C VIRUS INHIBITORS
    Publication number: 20080159982
    Abstract: Macrocyclic peptides having the general formula: are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: November 14, 2007
    Publication date: July 3, 2008
    Inventors: Alan Xiangdong Wang, Barbara Zhizhen Zheng, Stanley D'Andrea, Nicholas A. Meanwell, Paul Michael Scola
  • HEPATITIS C VIRUS INHIBITORS
    Publication number: 20080145334
    Abstract: Macrocyclic peptides having the general formula: are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: November 14, 2007
    Publication date: June 19, 2008
    Inventors: Alan Xiangdong Wang, Barbara Zhizhen Zheng, Stanley D'Andrea, Nicholas A. Meanwell, Paul Michael Scola
  • Hepatitis C virus inhibitors
    Publication number: 20060172950
    Abstract: Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R?, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: December 7, 2005
    Publication date: August 3, 2006
    Inventors: Xiangdong Wang, Li-Qiang Sun, Sing-Yuen Sit, Ny Sin, Paul Scola, Piyasena Hewawasam, Andrew Good, Yan Chen, Jeffrey Campbell
  • Hepatitis C virus inhibitors
    Publication number: 20050267040
    Abstract: Hepatitis C virus inhibitors are having the general formula: wherein A, R2, R3, R?, B and Y are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: November 18, 2004
    Publication date: December 1, 2005
    Inventors: Paul Scola, Jeffrey Campbell, Ny Sin, Li-Qiang Sun, Xiangdong Wang
  • Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
    Patent number: 6919331
    Abstract: The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: July 19, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kuo-Long Yu, Xiangdong Wang, Yaxiong Sun, Christopher Cianci, Jan Willem Thuring, Keith Combrink, Nicholas Meanwell, Yi Zhang, Rita L. Civiello
  • Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
    Patent number: 6844342
    Abstract: The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.
    Type: Grant
    Filed: August 19, 2003
    Date of Patent: January 18, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kuo-Long Yu, Rita L. Civiello, Keith D. Combrink, Hatice Belgin Gulgeze, Ny Sin, Xiangdong Wang, Nicholas Meanwell, Brian Lee Venables, Yi Zhang, Bradley C. Pearc, Zhiwei Yin, Jan Willem Thuring
  • Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
    Patent number: 6774134
    Abstract: The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.
    Type: Grant
    Filed: November 16, 2001
    Date of Patent: August 10, 2004
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kuo-Long Yu, Rita L. Civiello, Keith D. Combrink, Hatice Belgin Gulgeze, Ny Sin, Xiangdong Wang, Nicholas Meanwell, Brian Lee Venables, Yi Zhang, Bradley C. Pearce, Zhiwei Yin, Jan Willem Thuring
  • Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
    Publication number: 20040067997
    Abstract: The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.
    Type: Application
    Filed: August 19, 2003
    Publication date: April 8, 2004
    Inventors: Kuo-Long Yu, Rita L. Civiello, Keith D. Combrink, Hatice Belgin Gulgeze, Ny Sin, Xiangdong Wang, Nicholas Meanwell, Brian Lee Venables, Yi Zhang, Bradley C. Pearc, Zhiwei Yin, Jan Willem Thuring
  • Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
    Publication number: 20030207868
    Abstract: The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.
    Type: Application
    Filed: December 4, 2002
    Publication date: November 6, 2003
    Inventors: Kuo-Long Yu, Xiangdong Wang, Yaxiong Sun, Christopher Cianci, Jan Willem Thuring, Keith Combrink, Nicholas Meanwell, Yi Zhang, Rita L. Civiello
  • Benzimidazolone antiviral agents
    Patent number: 6506738
    Abstract: The present invention concerns antiviral compounds, their compositions, and use in the treatment of viral infections. More particularly, the invention provides benzimidazolone derivatives for the treatment of respiratory syncytial virus infection.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: January 14, 2003
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kuo-Long Yu, Rita Civiello, Keith Combrink, Hatice Belgin Gulgeze, Bradley C. Pearce, Xiangdong Wang, Nicholas A. Meanwell, Yi Zhang
  • Imidazopyridine and imidazopyrimidine antiviral agents
    Patent number: 6489338
    Abstract: The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides imidazopyridine and imidazopyrimidine derivatives (Formula I) for the treatment of respiratory syncytial virus infection.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: December 3, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kuo-Long Yu, Rita L. Civiello, Keith D. Combrink, Hatice Belgin Gulgeze, Ny Sin, Xiangdong Wang, Nicholas A. Meanwell, Brian Lee Venables
  • Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
    Publication number: 20020099208
    Abstract: The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.
    Type: Application
    Filed: November 16, 2001
    Publication date: July 25, 2002
    Inventors: Kuo-Long Yu, Rita L. Civiello, Keith D. Combrink, Hatice Belgin Gulgeze, Ny Sin, Xiangdong Wang, Nicholas Meanwell, Brian Lee Venables, Yi Zhang, Bradley C. Pearce, Zhiwei Yin, Jan Willem Thuring